Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,037
Closed -$1.17M 88
2025
Q3
$1.17M Hold
5,037
0.47% 32
2025
Q2
$935K Hold
5,037
0.42% 34
2025
Q1
$1.06M Hold
5,037
0.5% 31
2024
Q4
$895K Hold
5,037
0.32% 32
2024
Q3
$9.95M Hold
5,037
3.5% 7
2024
Q2
$864K Hold
5,037
0.34% 38
2024
Q1
$917K Hold
5,037
0.32% 45
2023
Q4
$781K Hold
5,037
0.3% 35
2023
Q3
$751K Hold
5,037
0.29% 43
2023
Q2
$679K Hold
5,037
0.27% 46
2023
Q1
$803K Hold
5,037
0.32% 48
2022
Q4
$814K Sell
5,037
-15,000
-75% -$2.3M 0.31% 49
2022
Q3
$2.69M Hold
20,037
1.13% 20
2022
Q2
$3.07M Hold
20,037
1.29% 20
2022
Q1
$3.25M Buy
20,037
+10,037
+100% +$1.46M 1.03% 27
2021
Q4
$1.35M Buy
+10,000
New +$1.18M 0.46% 46

Other funds holding ABBV

David M. Knott Jr's ABBV Position: Q4 2025 in Review

David M. Knott Jr sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 5,037 shares — an estimated $1.17M sold.

David M. Knott Jr first reported a position in ABBV in Q4 2021 and held it in 16 quarters. The position peaked at $9.95M in Q3 2024. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • David M. Knott Jr reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • David M. Knott Jr sold 5,037 AbbVie shares in Q4 2025, an estimated $1.17M.
  • David M. Knott Jr first reported a position in AbbVie in Q4 2021 and held it in 16 quarters.
  • David M. Knott Jr's AbbVie position peaked at $9.95M in Q3 2024.
  • 4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on David M. Knott Jr's 13F filing for Q4 2025, filed 12 Feb 2026.